Pharma Reviews: Panacea Biotec looks to scale up vaccine, pharma verticals to steer long-term growth

The Indian vaccine market was estimated to be around Rs 9,500 crore in 2019. During the year under review, the company has transferred its ...
Read more: Panacea Biotec looks to scale up vaccine, pharma verticals to steer long-term growth